Sera Prognostics Inc. (SERA)
NASDAQ: SERA
· Real-Time Price · USD
2.54
-0.26 (-9.29%)
At close: May 06, 2025, 3:59 PM
2.61
2.96%
After-hours: May 06, 2025, 07:03 PM EDT
-9.29% (1D)
| Bid | 2.5 |
| Market Cap | 93.04M |
| Revenue (ttm) | 77K |
| Net Income (ttm) | -32.9M |
| EPS (ttm) | -0.99 |
| PE Ratio (ttm) | -2.56 |
| Forward PE | -2.9 |
| Analyst | n/a |
| Ask | 3.3 |
| Volume | 161,720 |
| Avg. Volume (20D) | 112,683 |
| Open | 2.77 |
| Previous Close | 2.80 |
| Day's Range | 2.52 - 2.78 |
| 52-Week Range | 2.53 - 10.23 |
| Beta | 1.00 |
About SERA
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, g...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jul 15, 2021
Employees 63
Stock Exchange NASDAQ
Ticker Symbol SERA
Website https://seraprognostics.com
Next Earnings Release
Sera Prognostics Inc. is scheduled to release its earnings on May 7, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-9.44%
Sera Prognostics shares are trading lower after th...
Unlock content with
Pro Subscription
